ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy

Gut

Volumn 54, Issue 6, 2005, Pages 829-834

  Mullenbach R ^b   Bennett, A ^b   Tetlow, N ^b   Patel, N ^b   Hamilton, G ^b   Cheng, F ^b   Chambers, J ^b   Howard, R ^c   Taylor Robinson, S D ^b   Williamson, C ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c KING GEORGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; ATP8B1 GENE; BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE; GENE MUTATION; HUMAN; INTRAHEPATIC CHOLESTASIS; MAJOR CLINICAL STUDY; PHENOTYPE; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PREGNANCY; PRIORITY JOURNAL; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 1; SCREENING TEST; UNITED KINGDOM;

ADENOSINE TRIPHOSPHATASES; CHOLESTASIS, INTRAHEPATIC; ESTERS; FEMALE; GENETIC SCREENING; HETEROZYGOTE; HUMANS; LIVER; MAGNETIC RESONANCE SPECTROSCOPY; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS; SEQUENCE ANALYSIS;

EID: 21144447029     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2004.058115     Document Type: Article

References (49)

1. Kenyon AP, Nelson-Piercy C, Girling J, et al. Obstetric cholestasis, outcome with active management: a series of 70 cases. BJOG 2002;109:282-8.
2. Ch'ng CL, Morgan M, Hainsworth I, et al. Prospective study of liver dysfunction in pregnancy in Southwest Wales. Gut 2002;51:876-80.
3. Laotikainen T, Ikonen E. Serum bile acids in cholestasis of pregnancy. Obstet Gynecol 1977;50:313-18.
4. Reid R, Ivey KJ, Rencoret RH, et al. Fetal complications of obstetric cholestasis. Br Med J 1976;1:870-2.
5. Fisk NM, Storey GN. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988;95:1137-43.
6. Eloranta ML, Heinonen S, Mononen T, et al. Risk of obstetric cholestasis in sisters of index patients. Clin Genet 2001;60:42-5.
7. Bull LN, van Eijk MJ, Pawlikowska L, et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat Genet 1998;18:219-24.
8. Strautnieks SS, Bull LN, Knisely AS, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998;20:233-8.
9. de Vree JM, Jacquemin E, Sturm E, et al. Mutations in the MDR3 gene cause progressive familial intrahepatic cholestasis. Proc Natl Acad Sci U S A 1998;95:282-7.
10. Higgins CF. ABC transporters: from microorganisms to man. Annu Rev Cell Biol 1992;8:67-113.
11. Dixon PH, Weerasekera N, Linton KJ, et al. Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking. Hum Mol Genet 2000;9:1209-17.
12. Jacquemin E, Cresteil D, Manouvrier S, et al. Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999;353:210-11.
13. Rosmorduc O, Hermelin B, Poupon R. MDR3 gene defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001;120:1459-67.
14. Gendrot C, Bacq Y, Brechot MC, et al. A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med Genet 2003;40:e32.
15. Lucena JF, Herrero JI, Quiroga J, et al. A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis. Gastroenterology 2003;124:1037-42.
16. Mullenbach R, Linton KJ, Wiltshire S, et al. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 2003;40:E70.
17. Pauli-Magnus C, Lang T, Meier Y, et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004;14:91-102.
18. Jacquemin E, De Vree JM, Cresteil D, et al. The wide spectrum of multidrug resistance 3 deficiency: from neonatal cholestasis to cirrhosis of adulthood. Gastroenterology 2001;120:1448-58.
19. Klomp LW, Vargas JC, van Mil SW, et al. Characterization of mutations in ATP8B1 associated with hereditary cholestasis. Hepatology 2004;40:27-38.
20. Clayton RJ, Iber FL, Ruebner BH, et al. Byler disease. Fatal familial intrahepatic cholestasis in an Amish kindred. Am J Dis Child 1969;117:112-24.
21. de Pagter AG, van Berge Henegouwen GP, ten Bokkel Huinink JA, et al. Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives? Gastroenterology 1976;71:202-7.
22. Whitington PF, Freese DK, Alonso EM, et al. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J Pediatr Gastroenterol Nutr 1994;18:134-41.
23. Savander M, Ropponen A, Avela K, et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 2003;52:1025-9.
24. Cox U. Development and applications of in vivo clinical magnetic resonance spectroscopy. Prog Biophys Mol Biol 1996;65:45-81.
25. Girling JC, Dow E, Smith JH. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy. Br J Obstet Gynaecol 1997;104:246-50.
26. Klomp LW, Bull LN, Knisely AS, et al. A missense mutation in FIC1 is associated with greenland familial cholestasis. Hepatology 2000;32:1337-41.
27. Chen HL, Chang PS, Hsu HC, et al. FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low (gamma)- glutamyltranspeptidase levels. J Pediatr 2002;140:119-24.
28. Egawa H, Yorifuji T, Sumazaki R, et al. Intractable diarrhea after liver transplantation for Byler's disease: successful treatment with bile adsorptive resin. Liver Transpl 2002;8714-16.
29. Menon DK, Sargentoni J, Taylor-Robinson SD, et al. Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances. Hepatology 1995;21:417-27.
30. Jalan R, Sargentoni J, Coutts GA, et al. Hepatic phosphorus-31 magnetic resonance spectroscopy in primary biliary cirrhosis and its relation to prognostic models. Gut 1996;39:141-6.
31. Taylor-Robinson SD, Sargentoni J, Bell JD, et al. In vivo and in vitro hepatic 31P magnetic resonance spectroscopy and electron microscopy of the cirrhotic liver. Liver 1997;17:198-209.
32. Taylor-Robinson SD, Sargentoni J, Bell JD, et al. In vivo and in vitro hepatic phosphorus-31 magnetic resonance spectroscopy and electron microscopy in chronic ductopenic rejection of human liver allografts. Gut 1998;42:735-43.
33. Ordidge RJ, Bowley RM, McHale G. A general approach to selection of multiple cubic volume elements using the ISIS technique. Magn Reson Med 1988;8:323-31.
34. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129:35-43.
35. van den Boogaart A, Van Hecke P, Van Huffel S, et al. MRUI: a graphical user interface for accurate routine MRS data analysis, Proceedings of the ESMRMB 13th Annual Meeting, Prague, 1996:318.
36. Hamilton G, Patel N, Forton DM, et al. Prior knowledge for time domain quantification of in vivo brain or liver 31P MR spectra. NMR Biomed 2003;16:168-76.
37. Ujhazy P, Ortiz D, Misra S, et al. Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology 2001;34(4 Pt 1):768-75.
38. Elferink RO, Groen AK. Genetic defects in hepatobiliary transport. Biochim Biophys Acta 2002;1586:129-45.
39. Chen F, Ananthanarayanan M, Emre S, et al. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased rarnesoid X receptor activity. Gastroenterology 2004;126:756-64.
40. Halleck MS, Lawler JJ, Blackshaw S, et al. Differential expression of putative transbilayer amphipath transporters. Physiol Genomics 1999;1:139-50.
41. Halleek MS, Pradhan D, Blackman C, et al. Multiple members of a third subfamily of P-type ATPases identified by genomic sequences and ESTs. Genome Res 1998;8:354-61.
42. Leabman MK, Huang CC, DeYoung J, et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A 2003;100:5896-901.
43. Rosario J, Sutherland E, Zaccaro L, et al. Ethinylestradiol administration selectively alters liver sinusoidal membrane lipid fluidity and protein composition. Biochemistry 1988;27:3939-46.
44. Simon FR, Fortune J, Iwahashi M, et al. Ethinyl estradiol cholestasis involves alterations in expression of liver sinusoidal transporters. Am J Physiol 1996;271(6 Pt 1):G1043-52.
45. Green RM, Hoda F, Ward KL. Molecular cloning and characterization of the murine bile salt export pump. Gene 2000;241:117-23.
46. Geier A, Dietrich CG, Gerloff T, et al. Regulation of basolateral organic anion transporters in ethinylestradiol-induced cnolestasis in the rat. Biochim Biophys Acta 2003;1609:87-94.
47. Micheline D, Emmanuel J, Serge E. Effect of ursodeoxycholic acid on the expression of the hepatocellular bile acid transporters (Ntcp and bsep) in rats with estrogen-induced cholestasis. J Pediatr Gastroenterol Nutr 2002;35:185-91.
48. Rodien P, Bremont C, Sanson ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998;339:1823-6.
49. Bell JD, Cox IJ, Sargentoni J, et al. A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver. Biochim Biophys Acta 1993;1225:71-7.